NCT06649331 2026-03-17Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast CancerFudan UniversityPhase 2 Recruiting160 enrolled
NCT07393425 2026-02-06Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast CancerShanghai Jiao Tong University School of MedicinePhase 2 Recruiting50 enrolled